Middle East And Africa Avidin Market Size & Outlook, 2026-2034


Middle East And Africa Avidin Market Insights

  • Reed Intelligence analysis indicates that the Middle East And Africa Avidin Market size, which was USD 20.08 Million in 2025, is projected to attain USD 37.97 Million by 2034.
  • The market is expected to register a CAGR of 7.44% over the period 2026–2034.
  • In 2025, Avidin emerged as the dominant Type based on market size.
  • Streptavidin is projected to register the fastest growth, positioning it as the most attractive Type segment over the forecast horizon.

Other Key Findings


  • In 2025, Middle East And Africa contributed 9.34% to the overall global Avidin Market size.
  • By 2034, United States is anticipated to dominate the global market based on market size.
  • Saudi Arabia is expected to witness the fastest growth within Middle East and Africa, attaining USD 6.64 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 20.08 Million
Market Size In 2034 USD 37.97 Million
Largest segment Avidin
Units Revenue in USD Million
CAGR 7.44% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Type
  1. Avidin
  2. Streptavidin
  3. Neutravidin
Application
  1. Immunoassays
  2. Molecular Diagnostics
  3. Protein Purification
  4. Research and Development
End-Use
  1. Biotechnology and Pharmaceutical Companies
  2. Academic and Research Institutes
  3. Diagnostic Laboratories
Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Middle East Africa
  5. Latin America
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends